MST1R 基因变异使个体易患法洛特四分法
Zhiyu Feng1,2, Xianghui Huang3, Yuan Gao1,2
1Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201002 China.
Phenomics (Cham, Switzerland)
|March 10, 2025
概括
巨刺激1受体 (MST1R) 基因中的遗传变异与法洛特四分法 (TOF) 有关. 缺乏MST1R会损害心肌细胞的功能,这表明它在TOF病变发生过程中的作用.
科学领域:
- 心血管遗传学 心血管遗传学
- 发展生物学 发展生物学
- 免疫学 免疫学 免疫学
背景情况:
- 费洛特四重症 (TOF) 是最常见的阴影性先天性心脏缺陷,但其遗传基础仍然不完全理解.
- 参与免疫防御的巨刺激1受体 (MST1R) 基因尚未被广泛研究与先天性心脏形有关.
研究的目的:
- 为了调查Fallot四方论 (TOF) 的遗传基础.
- 探索巨刺激1受体 (MST1R) 基因在心脏发育和TOF病变发生中的作用.
主要方法:
- 在10个TOF家族和50个零星TOF患者身上进行了全外体测序 (WES).
- 在417名TOF患者中进行了MST1R的向测序.
- 人类诱导多能干细胞 (hiPSCs) 产生并分化为心肌细胞 (CMs).
主要成果:
- 在一个家族的两个TOF后代中,在MST1R中发现了一种衰退性同卵性误解突变 (c.T2009G:p.V670G).
- 与gnomADv2_EAS数据库相比,TOF患者中罕见的MST1R变种得到了丰富.
- 缺乏MST1R的hiPSCs表现出正常的多能性,但未能分化为功能性CMs.
结论:
- MST1R在心脏分化中起着至关重要的作用.
- 在MST1R的遗传变异与Fallot的四分论的发病有关.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


